AtheroNova Operations, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Central District Of California on March 2, 2015. The affiliate include AtheroNova Inc. The debtor listed its assets of $0.79 million and liabilities of $5.43 million. The largest unsecured creditors include Belro Medical S.A., California State University Regents, Frontage Laboratories, Inc., LifeSci Advisors, LLC, McDermott Will & Emery LLP, MPI Research, Inc., Bio-Newco, Inc., Sharp Clinical Services, Inc., Stradling Yocca Carlson & Rauth, P.C. and Weinberg & Company, P.A. Ron Bender and Lindsey L Smith of Levene, Neale, Bender, Yoo & Brill LLP and Louis Wharton of Stubbs Alderton & Markiles, LLP acted as legal counsels for the debtor.

The debtor hired Sherwood Partners, LLC as financial advisor.